A detailed history of Acg Wealth transactions in Catalent, Inc. stock. As of the latest transaction made, Acg Wealth holds 35,806 shares of CTLT stock, worth $2.18 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
35,806
Previous 33,605 6.55%
Holding current value
$2.18 Million
Previous $3.61 Million 28.13%
% of portfolio
0.59%
Previous 0.74%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$72.36 - $113.1 $159,264 - $248,933
2,201 Added 6.55%
35,806 $2.59 Million
Q2 2022

Jul 13, 2022

BUY
$87.2 - $114.05 $273,808 - $358,117
3,140 Added 10.31%
33,605 $3.61 Million
Q1 2022

Apr 07, 2022

BUY
$94.19 - $124.49 $2.87 Million - $3.79 Million
30,465 New
30,465 $3.38 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.